CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Others(No intervention)Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug392 Hydroxychloroquine as post exposure prophylaxis Wiki 1.00
drug946 convalescent plasma Wiki 0.71

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D003289 Convalescence NIH 0.71

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 A Study of Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial)

There is no known definite treatment after exposure to SARS-CoV-2, but the some animal and clinical trials confirmed the efficacy of hydroxychloroquine (HCQ) or chloroquine against SARS-CoV-2. Thus, in this study, we aim to evaluate the efficacy and safety of hydroxychloroquine as post exposure prophylaxis for SARS-CoV-2. - Primary end point: comparison the rate of COVID-19 between PEP with HCQ and control group. - Secondary end point: Comparison of the rate of COVID-19 according to the contact level (time, place, degree of wearing personal protective equipment). - Safety comparison: Safety verification by identifying major side effects in the HCQ group."

NCT04330144 Contact Person From COVID-19 Confirmed Patient Drug: Hydroxychloroquine as post exposure prophylaxis Other: Others(No intervention)

Primary Outcomes

Description: After postexposure prophylaxis, the rate of COVID-19 conversion between two groups

Measure: The rate of COVID-19

Time: PCR test of COVID-19 at 14 days after the contact from confirmed case


No related HPO nodes (Using clinical trials)